TKNO
Price
$7.39
Change
+$0.59 (+8.68%)
Updated
Oct 20 closing price
Capitalization
396.76M
15 days until earnings call
Intraday BUY SELL Signals
ZYBT
Price
$1.49
Change
+$0.04 (+2.76%)
Updated
Oct 20 closing price
Capitalization
70.61M
Intraday BUY SELL Signals
Interact to see
Advertisement

TKNO vs ZYBT

TKNO vs ZYBT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
TKNO vs. ZYBT commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKNO is a Hold and ZYBT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for TKNO with price predictions
Oct 20, 2026

TKNO's RSI Indicator recovers from oversold territory

The RSI Indicator for TKNO moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 29 of the 32 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where TKNO advanced for three days, in 222 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

TKNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TKNO as a result. In 72 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for TKNO turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 41 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

TKNO moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TKNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.338) is normal, around the industry mean (10.819). P/E Ratio (-23.839) is within average values for comparable stocks, (-7.131). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (8.718) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. TKNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 83 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TKNO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for ZYBT with price predictions
Oct 20, 2026

ZYBT's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for ZYBT moved out of overbought territory on October 12, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In 10 of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

ZYBT moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ZYBT crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZYBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

ZYBT broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ZYBT entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on ZYBT as a result. In 30 of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for ZYBT just turned positive on October 09, 2026. Looking at past instances where ZYBT's MACD turned positive, the stock continued to rise in 10 of 13 cases over the following month. The odds of a continued upward trend are 77%.

Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZYBT advanced for three days, in 62 of 77 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ZYBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.656) is normal, around the industry mean (10.819). P/E Ratio (0.000) is within average values for comparable stocks, (-7.131). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (178.797).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZYBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
TKNOZYBT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (TKNO: $7.39 vs. ZYBT: $1.49)
Brand notoriety: TKNO and ZYBT are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TKNO: 88% vs. ZYBT: 4%
Market capitalization -- TKNO: $396.76M vs. ZYBT: $70.61M
TKNO [@Pharmaceuticals: Generic] is valued at $396.76M. ZYBT’s [@Pharmaceuticals: Generic] market capitalization is $70.61M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKNO’s FA Score shows that 1 FA rating(s) are green while ZYBT’s FA Score has 0 green FA rating(s).

  • TKNO’s FA Score: 1 green, 4 red.
  • ZYBT’s FA Score: 0 green, 5 red.
According to our system of comparison, both TKNO and ZYBT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKNO’s TA Score shows that 4 TA indicator(s) are bullish while ZYBT’s TA Score has 4 bullish TA indicator(s).

  • TKNO’s TA Score: 4 bullish, 4 bearish.
  • ZYBT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, TKNO is a better buy in the short-term than ZYBT.

Price Growth

TKNO (@Pharmaceuticals: Generic) experienced а -10.10% price change this week, while ZYBT (@Pharmaceuticals: Generic) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.61%. For the same industry, the average monthly price growth was -6.52%, and the average quarterly price growth was +9.62%.

Reported Earning Dates

TKNO is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
TKNO
Daily Signal:
Gain/Loss:
ZYBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BAVA26.210.27
+1.06%
Bitwise Avalanche ETF (BAVA)
DDWM45.910.41
+0.90%
WisdomTree Dynamic International Equity Fund (DDWM)
EVX40.130.33
+0.82%
VanEck Environmental Services ETF (EVX)
IDMY24.94N/A
N/A
Corgi International Developed Equities 15% Structured Buffer ETF - May (IDMY)
GARY26.90-0.01
-0.04%
Mango Growth ETF (GARY)

TKNO and

Correlation & Price change

A.I.dvisor tells us that TKNO and CRON have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKNO and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
+8.68%
CRON - TKNO
31%
Poorly correlated
+0.92%
ACB - TKNO
27%
Poorly correlated
+0.25%
EBS - TKNO
27%
Poorly correlated
-1.10%
SNDL - TKNO
26%
Poorly correlated
+1.99%
BIOA - TKNO
25%
Poorly correlated
+11.42%
More

ZYBT and

Correlation & Price change

A.I.dvisor tells us that ZYBT and PRGO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYBT and PRGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYBT
1D Price
Change %
ZYBT100%
+2.76%
PRGO - ZYBT
27%
Poorly correlated
+0.50%
AYTU - ZYBT
27%
Poorly correlated
+2.55%
UTHR - ZYBT
23%
Poorly correlated
+1.98%
NBIX - ZYBT
20%
Poorly correlated
+3.66%
TKNO - ZYBT
16%
Poorly correlated
+8.68%
More